Lifecore Biomedical
LFCR
92 hedge funds and large institutions have $374M invested in Lifecore Biomedical in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 34 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
9% more capital invested
Capital invested by funds: $343M → $374M (+$30.1M)
3% more funds holding
Funds holding: 89 → 92 (+3)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.69% less ownership
Funds ownership: 95.66% → 90.98% (-4.7%)
26% less repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 34
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ICOM
Investment Counselors of Maryland
Baltimore,
Maryland
|
+$3.03M |
| 2 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$2.75M |
| 3 |
BlackRock
New York
|
+$1.28M |
| 4 |
AG
Algert Global
San Francisco,
California
|
+$1.12M |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
+$1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Russell Investments Group
London,
United Kingdom
|
-$6.45M |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$4.89M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$2.28M |
| 4 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
-$1.25M |
| 5 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
-$740K |
LFCR Hedge Fund Activity: Q2 2018 in Review
92 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q2 2018, worth a combined $374M — up 8.8% from $343M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new LFCR positions and 5 closed out — a net gain of 4 holders — while 25 added to existing stakes and 34 trimmed.
The largest buyer was Investment Counselors of Maryland, adding an estimated $3.03M. The largest seller was Russell Investments Group, cutting an estimated $6.45M.
- 92 institutional investors held Lifecore Biomedical (LFCR) as of Q2 2018, up from 89 in Q1 2018.
- Funds reported $374M of Lifecore Biomedical stock for Q2 2018, up 8.8% quarter-over-quarter.
- 9 funds opened new Lifecore Biomedical positions in Q2 2018 and 5 closed out, a net change of +4 holders.
- The largest Lifecore Biomedical buyer in Q2 2018 was Investment Counselors of Maryland, an estimated $3.03M added.
- The largest Lifecore Biomedical seller in Q2 2018 was Russell Investments Group, an estimated $6.45M sold.
Based on aggregated 13F filings for Q2 2018.